What is the DRUG stock price prediction for next 2 weeks?

According to our price prediction algorithm,Bright Minds Biosciences Inc. (DRUG) price will be around $98.32 in the next 2 weeks. This means it will increase by 11.785105173393967 from the last closing price. This prediction may vary from other time period filters for DRUG stock.

What can be the highest Possible price of DRUG stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, DRUG can achieve the highest price of $102.45 which is 16.487641655231673 higher than last closing price. This prediction may vary from other time period filters for DRUG stock.

What can be the lowest Possible price of DRUG stock in next 2 weeks?

As per the forecast and algorithmic analysis, DRUG stock price can be as low as $94.27 which is 7.188457273531906 higher than the current price in the next 2 weeks. This prediction may vary from other time period filters for DRUG stock.

Will DRUG stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that DRUG stock will gain11.785105173393967 in the next 2 weeks. This prediction may vary from other time period filters for DRUG stock.

What is DRUG stock last closing price?

Last closing price of DRUG stock was $87.95.

What is DRUG stock price prediction?

DRUG stock price prediction means predicting the future closing prices of DRUG stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of DRUG stock in a certain time period.

How we predict DRUG stock future prices?

If you are searching for DRUG stock forecast, analysis or price prediction, then you might be wondering what Bright Minds Biosciences Inc. (DRUG) will do in the future. Our DRUG price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This DRUG price prediction will likely answer most of your questions.

How frequent we update DRUG stock predictions?

We are updating the forecasts for the DRUG stock on daily basis.

Is using ML forecasting for DRUG stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for DRUG stock same for all the time periods?

No, the prediction for DRUG stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Bright Minds Biosciences Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$87.95-3.13%Since 2 Weeks

Predicted Price$98.3211.79%For 2 Weeks

Upper Predicted Price$102.4516.49%For 2 Weeks

Lower Predicted Price$94.277.19%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of DRUG will rise by +11.79% over the next 2 Weeks and hit $98.32 by Thursday, May 14, 2026. In that time frame, DRUG's share price is expected to range between $94.27 and $102.45.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
May 14, 2026	96.16	100.53	104.96
May 13, 2026	95.81	99.96	104.69
May 12, 2026	95.93	99.99	104.42
May 11, 2026	94.83	99.31	103.52
May 8, 2026	93.17	97.63	101.72
May 7, 2026	91.77	96.44	100.53
May 6, 2026	91.68	95.87	99.90
May 5, 2026	91.63	95.90	100.34
May 4, 2026	90.71	95.22	99.71
May 1, 2026	89.42	93.54	97.92

DRUG shares fell -4.55% in Monday, May 4, 2026's trading session, dropping from a previous close of $86.96 to move at $83.01. The stock demonstrated notable intraday movement (see DRUG's key stats for a full breakdown), fluctuating between $81.29 and $87.50, a +7.64% trading range. While recent weeks have seen some volatility, DRUG has managed to secure a -6.37% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 160.83K shares changing hands, 2.75K fewer than the previous session. This amounted to $13.35M in total market activity.

Will DRUG Continue Its Upward Trend?

According to analyst ratings and projections for DRUG, Bright Minds Biosciences Inc. shares are anticipated to increase by +20.92%, potentially reaching $104.96 per share by May 14, 2026. Short-term technical indicators currently suggest a neutral sentiment for DRUG. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the DRUG stock forecast, now is a good time to buy DRUG stock because its current trading price is -17.43% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on DRUG covering social and institutional perspectives.

DRUG Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into DRUG's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 38.55% to 49.72%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 52.30%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 53.56%, maintains a neutral outlook for the long term. Insights into DRUG's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Bright Minds Biosciences Short-Term Forecasts

DRUG Forecast For Next 5 Days

Our algorithm anticipates Bright Minds Biosciences (DRUG) stock could hit $76.33 by May 11, 2026. This represents a -8.04% fall from today's price, following a -6.39% change over the past five days.

DRUG Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Bright Minds Biosciences Inc. (DRUG) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $83.56, which would mean a +0.67% increase from the current price of $83.01. Projections for this period range from a high of $97.79 to a low of $69.48.

DRUG Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Bright Minds Biosciences's price over the next three months point to a drop. DRUG stock is expected to peak at $83.77 on Jul 24, 2026 after potentially dipping to $58.87 on May 18, 2026. On average, DRUG is likely to trade around $72.66 in the coming 90 days.

Bright Minds Biosciences Stock Forecast 2025

Based on our predictive models, Bright Minds Biosciences (DRUG) is expected to trade between $58.87 and $103.65 throughout 2026. This would result in an average price of $77.59, potentially offering investors a -6.52% return from current levels.

Bright Minds Biosciences Inc. Monthly Forecast 2026–2027

May 2026

According to our latest forecast models, Bright Minds Biosciences Inc. (DRUG) is positioned to show a strong performance in May 2026. The price is predicted to move between $58.87 and $74.53, settling at an average of $66.33. This could translate to a -20.09% loss.

June 2026

Based on current market signals, Bright Minds Biosciences Inc. is projected to trend june 2026. We forecast a trading range from $62.29 to $83.24, with a likely average price of $75.17. Investors could expect a potential return of -9.44%.

July 2026

Our predictive algorithms indicate Bright Minds Biosciences Inc. stock may see a shift in July 2026. The expected range spans $67.58–$83.77, with an average target of $75.58. This represents a cautious outlook and a possible loss of -8.95%.

August 2026

Analyzing established trends, Bright Minds Biosciences Inc. looks set to move in August 2026. Projections place the stock between $68.18 and $83.05, averaging around $75.40. This suggests a -9.16% loss from current levels.

September 2026

Market indicators suggest Bright Minds Biosciences Inc. could experience notable changes during September 2026. Prices could fluctuate within $68.51 to $83.11, with a midpoint forecast of $75.92. The stock might deliver a -8.54% loss.

October 2026

Forecasting for October 2026, models estimate that Bright Minds Biosciences Inc. may undergo key fluctuations. If trends hold, the stock might trade between $65.02 and $84.66, averaging $77.37. This signals a cautious trajectory with potential returns around -6.79%.

November 2026

According to our latest forecast models, Bright Minds Biosciences Inc. (DRUG) is positioned to show a strong performance in November 2026. The price is predicted to move between $77.29 and $103.65, settling at an average of $87.46. This could translate to a +5.37% gain.

December 2026

Based on current market signals, Bright Minds Biosciences Inc. is projected to trend december 2026. We forecast a trading range from $79.73 to $94.17, with a likely average price of $86.48. Investors could expect a potential return of +4.19%.

January 2027

Our predictive algorithms indicate Bright Minds Biosciences Inc. stock may see a shift in January 2027. The expected range spans $78.97–$94.18, with an average target of $86.25. This represents a positive outlook and a possible gain of +3.91%.

February 2027

Analyzing established trends, Bright Minds Biosciences Inc. looks set to move in February 2027. Projections place the stock between $79.86 and $94.52, averaging around $87.05. This suggests a +4.87% gain from current levels.

March 2027

Market indicators suggest Bright Minds Biosciences Inc. could experience notable changes during March 2027. Prices could fluctuate within $81.40 to $97.49, with a midpoint forecast of $88.69. The stock might deliver a +6.85% gain.

April 2027

Forecasting for April 2027, models estimate that Bright Minds Biosciences Inc. may undergo key fluctuations. If trends hold, the stock might trade between $88.47 and $105.35, averaging $97.96. This signals a positive trajectory with potential returns around +18.02%.

DRUG's history of dividends and stock splits also plays a role in long-term investor confidence.